Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2013 by The Hospital for Sick Children
Sponsor:
Information provided by (Responsible Party):
Eleanor Hendershot, The Hospital for Sick Children
ClinicalTrials.gov Identifier:
NCT01176981
First received: August 3, 2010
Last updated: August 23, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)